Log in
NASDAQ:MDRX

Allscripts Healthcare Solutions Stock Forecast, Price & News

$14.21
+0.03 (+0.21 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$13.98
Now: $14.21
$14.31
50-Day Range
$8.31
MA: $11.20
$14.20
52-Week Range
$4.56
Now: $14.21
$14.48
Volume504,443 shs
Average Volume2.11 million shs
Market Capitalization$2.24 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.94
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions. The company operates in two segments, Provider and Veradigm. The Provider segment provides integrated clinical software applications, financial management, and patient engagement solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Veradigm segment offers data-driven clinical insights with actionable tools for clinical workflow, research, analytics, and media. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Read More
Allscripts Healthcare Solutions logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.89 out of 5 stars


Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDRX
CUSIP01988P10
Phone800-334-8534
Employees9,600

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Cash Flow$2.74 per share
Book Value$7.65 per share

Profitability

Net Income$-182,180,000.00

Miscellaneous

Market Cap$2.24 billion
Next Earnings Date3/1/2021 (Estimated)
OptionableOptionable
$14.21
+0.03 (+0.21 %)
(As of 11/27/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

How has Allscripts Healthcare Solutions' stock price been impacted by COVID-19 (Coronavirus)?

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDRX shares have increased by 125.2% and is now trading at $14.21.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Allscripts Healthcare Solutions?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 4 sell ratings, 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Allscripts Healthcare Solutions
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Allscripts Healthcare Solutions?

Wall Street analysts have given Allscripts Healthcare Solutions a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Allscripts Healthcare Solutions wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for Allscripts Healthcare Solutions
.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) released its quarterly earnings data on Tuesday, November, 3rd. The software maker reported $0.20 earnings per share for the quarter, beating analysts' consensus estimates of $0.19 by $0.01. The software maker had revenue of $402 million for the quarter, compared to analyst estimates of $419.75 million. Allscripts Healthcare Solutions had a negative net margin of 2.77% and a positive return on equity of 5.80%. The business's revenue was down 9.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.17 EPS.
View Allscripts Healthcare Solutions' earnings history
.

What price target have analysts set for MDRX?

15 equities research analysts have issued 12-month price targets for Allscripts Healthcare Solutions' shares. Their forecasts range from $5.50 to $16.50. On average, they anticipate Allscripts Healthcare Solutions' share price to reach $10.37 in the next year. This suggests that the stock has a possible downside of 27.0%.
View analysts' price targets for Allscripts Healthcare Solutions
.

Who are some of Allscripts Healthcare Solutions' key competitors?

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Energy Transfer (ET), CVS Health (CVS), Ford Motor (F), Himax Technologies (HIMX), Intel (INTC), OPKO Health (OPK), Tesla (TSLA) and Activision Blizzard (ATVI).

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the following people:
  • Mr. Paul M. Black, CEO & Director (Age 62, Pay $1.27M)
  • Mr. Richard J. Poulton, Pres & CFO (Age 55, Pay $743.46k)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 53, Pay $690.49k)
  • Mr. Joseph R. Rostock, Sr. VP of Devel. & CTO (Age 57)
  • Mr. Brennan Sullivan, VP & Chief Information Officer
  • Mr. Stephen M. Shulstein, VP of Investor Relations
  • Ms. Tejal Vakharia, Sr. VP & Gen. Counsel
  • Mr. Richard Elmore, Sr. VP of Corp. Devel. & Strategy
  • Ms. Leah Jones, Sr. VP of Sales Operations
  • Ms. Rebecca Whaley, VP of Marketing

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.30%), Fisher Asset Management LLC (3.92%), Fuller & Thaler Asset Management Inc. (3.80%), State Street Corp (3.47%), JPMorgan Chase & Co. (2.22%) and Charles Schwab Investment Management Inc. (0.96%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Lisa Khorey, Mara G Aspinall, Paul Black, Richard J Poulton and Yancey L Spruill.
View institutional ownership trends for Allscripts Healthcare Solutions
.

Which major investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., Fuller & Thaler Asset Management Inc., JPMorgan Chase & Co., AQR Capital Management LLC, Royce & Associates LP, Paradigm Capital Management Inc. NY, Engineers Gate Manager LP, and Fisher Asset Management LLC. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis, Lisa Khorey, and Paul Black.
View insider buying and selling activity for Allscripts Healthcare Solutions
.

Which major investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Wells Fargo & Company MN, Cubist Systematic Strategies LLC, AXA S.A., Candriam Luxembourg S.C.A., Principal Financial Group Inc., Meeder Asset Management Inc., and AJO LP. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Paul Black, Richard J Poulton, and Yancey L Spruill.
View insider buying and selling activity for Allscripts Healthcare Solutions
.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $14.21.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $2.24 billion and generates $1.77 billion in revenue each year. The software maker earns $-182,180,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,600 workers across the globe.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]

This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.